جست‌وجوی استاد و پژوهشگر

Sourav Bandyopadhyayمشاهده پروفایل

استاد

• Cancer Biology
• Systems Biology
• Bioinformatics
• +۵ مورد دیگر

Sourav Bandyopadhyay is a Professor in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco (UCSF). He serves as Associate Director of the Quantitative Biosciences Institute (QBI) and Coleader of the Molecular Oncology Program. His research focuses on understanding cancer biology through systems-level analysis of biological networks, with emphasis on drug resistance mechanisms in breast and lung cancers. Education includes: PhD in Bioinformatics and Systems Biology, University of California San Diego (2010) Computer Science & Molecular Biology, University of Wisconsin (2002) Research combines functional genomics, proteomics, and computational approaches to identify synthetic lethal interactions and develop personalized cancer therapies. Key interests include cancer network plasticity, drug resistance mechanisms, and precision oncology applications. The Bandyopadhyay Lab employs high-throughput screening and computational algorithms to translate findings into clinical applications. Publications demonstrate consistent focus on cancer signaling networks, drug resistance mechanisms, and host-pathogen interactions. Recent work explores kinase signaling rewiring in hepatocellular carcinoma (2025), FAK-YAP axis in lung cancer persistence (2024), and inflammatory subpopulations in chemotherapy resistance (2024). Awards include the UCSF Faculty Fellowship for exceptional early-career scientists. Leads the Bandyopadhyay Lab which collaborates extensively with clinicians, biotechnologists, and pharmaceutical partners to advance cancer therapeutics.

• Genomics
• Bioinformatics
• Computational Biology
• +۷ مورد دیگر

Dr. Naftali Kaminski is the Boehringer Ingelheim Endowed Professor of Internal Medicine and Chief of Pulmonary, Critical Care and Sleep Medicine at Yale School of Medicine . Previously, he held multiple tenured professorships at the University of Pittsburgh, including the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research and directorship of the Simmons Center for Interstitial Lung Disease. He received his medical degree from Hebrew University-Hadassah Medical School and completed clinical training at Hadassah Mount-Scopus University Hospital and Sheba Medical Center in Israel, followed by postdoctoral research at UCSF and Roche Bioscience. Research Focus: Genomics and systems biology of chronic lung diseases, particularly Idiopathic Pulmonary Fibrosis (IPF), COPD, and sarcoidosis Key Contributions: Discovery of microRNA roles in fibrosis, novel biomarkers for IPF outcomes, antifibrotic thyroid hormone signaling, and creation of the IPF Cell Atlas (www.IPFCellAtlas.com) Leadership: President of APCSD, Deputy Editor for Thorax , and Fellow of the European Respiratory Society and American Thoracic Society Scientific Awards: Amberson Lecture Award (ATS, 2022) Andy Tager Excellence in Mentorship Award (ATS, 2018) Blavatnik Innovation Award (Yale, 2018) European Respiratory Society Gold Medal (2016) Helmholtz Institute International Fellow (2013) Publications: Over 340 peer-reviewed articles in Nature Medicine , NEJM , Science Advances , and Lancet Respiratory Medicine , including recent single-cell RNAseq studies and computational models for fibrosis.

Enni Markkanenمشاهده پروفایل

استاد

• Comparative Oncology
• Cancer-associated Stroma
• Soft-tissue Sarcomas
• +۷ مورد دیگر

Enni Markkanen is a full Professor of Pharmacotherapy and Toxicology at the Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich. Her research bridges comparative oncology and molecular pathology through translational studies across human, canine, and feline cancer models. Focus on cancer-associated stroma mechanisms Development of cross-species sarcoma models Expertise in laser-capture microdissection and omics analysis Key research themes include: Comparative Oncology: Leveraging natural cancers in pets to understand human tumor biology. Stromal Reprogramming: Mechanistic analysis of cancer-stroma interactions using RNAseq and proteomics. DNA Damage Response: Investigating BER pathway deficiencies in genetic instability and neuropsychiatric conditions. Recent publications demonstrate cross-disciplinary impact through: Proteomic characterization of canine fibrosarcoma Identification of conserved stromal disease drivers Development of fluorescence-guided surgical tools Molecular mapping of stress response activation Her work has produced 15 recent publications (2021-2025) spanning Nature Communications , Neoplasia , and Cancers , focusing on: Single-species and cross-species tumor comparison Stromal reprogramming mechanisms DNA damage response pathways Translational imaging and therapeutic strategies

Md Mehedi Hasanمشاهده پروفایل

استادیار

• Bioinformatics
• Machine Learning
• Deep Learning
• +۷ مورد دیگر

Md Mehedi Hasan serves as Research Assistant Professor in the Department of Pathobiological Sciences at Louisiana State University's School of Veterinary Medicine, appointed November 13, 2023. His academic trajectory spans Bangladesh, China, and Japan, reflecting a globally integrated research approach focused on computational biology solutions for veterinary medicine. His educational foundation includes: PhD in Bioinformatics, China Agricultural University (2016) MSc in Statistics, Rajshahi University, Bangladesh (2012) BSc in Statistics, Rajshahi University, Bangladesh (2010) Dr. Hasan's research bridges machine learning and genomic data science , specializing in next-generation sequencing analysis (bulk/single-cell RNAseq, ATACseq, spatial transcriptomics) and epigenetic modification prediction. His innovative work develops deep learning frameworks for RNA/DNA methylation site identification and protein structure analysis, creating practical tools like Deepm5C and Meta-i6mA that advance precision veterinary diagnostics. This computational expertise enables novel insights into host-pathogen interactions and neurobiological impacts of infections. His scientific recognition includes: JSPS Postdoctoral Fellowship (2019) Chinese Scholarship Council PhD Award (2012) Multiple merit-based undergraduate awards in Bangladesh Dr. Hasan actively mentors students in NGS data analysis and bioinformatics tool development , with recent publications demonstrating strong grant support. His international collaborations—particularly with Japanese institutions—enhance research scope while providing students global networking opportunities. The lab emphasizes practical computational skills applicable to veterinary genomics challenges, with growing capacity for complex multi-omics projects since his 2023 appointment. Current research directions focus on integrating spatial transcriptomics with machine learning to model tissue-specific disease mechanisms, while expanding epigenetic prediction tools for veterinary applications. This positions his lab at the forefront of computational veterinary medicine.

Valeria Cavalliمشاهده پروفایل

استاد

• Axon Regeneration
• Peripheral Nervous System
• Central Nervous System
• +۴ مورد دیگر

Valeria Cavalli, PhD, is the Robert E. and Louise F. Dunn Professor of Biomedical Research and Professor of Neuroscience at Washington University School of Medicine. Her research focuses on axon regeneration mechanisms in sensory neurons and the role of satellite glial cells in sensory function and dysfunction. She leads the Cavalli Lab, which investigates molecular pathways in peripheral and central nervous system repair using biochemistry, cell biology, in vivo imaging, and single-cell sequencing approaches. Education: BS and Master in Biochemistry, University of Geneva, Switzerland (1987-1992) Predoctoral Research, University of Rome "La Sapienza" (1991-1994) Predoctoral Research, Biozentrum, Basel, Switzerland (1994-1995) PhD in Biochemistry, University of Geneva, Switzerland (1995-2000) Research Interests: Dr. Cavalli's work centers on intrinsic mechanisms of axon regeneration, satellite glial cell contributions to neural repair, and therapeutic strategies for CNS injuries. Her lab studies neurodevelopmental disorders (e.g., Fragile X syndrome), aging-related sensory decline, and multicellular interactions in dorsal root ganglia. Key projects include epigenetic reprogramming after injury, endothelin receptor pathways, and macrophage-mediated regeneration. Publication Trends: Her recent articles (2021-2024) emphasize single-cell transcriptomics of sensory neurons, glial-neuronal interactions in pain/regeneration, and interventions for neurodevelopmental/aging models. Dominant themes include chromatin remodeling, receptor signaling (e.g., Endothelin B, GABAa), and cross-species molecular conservation. Awards: Robert E. and Louise F. Dunn Professorship (2021) NINDS Research Program Award (R35, 2020) Stein Innovation Award (2019) Jack Griffin Plenary Lecture (2019) Distinguished Investigator Award (2014) Advising & Grants: Dr. Cavalli mentors 19+ trainees (PhD/Master's students and postdocs) and secured major funding including an R35 award for "Multicellular Mechanisms Driving Axon Regeneration." Her lab collaborates with WashU departments (Genetics, Neurology, Anesthesiology) and external institutions like Weizmann Institute. Lab & Team: The Cavalli Lab comprises postdoctoral fellows, staff scientists, and undergraduates. Current members include Sarah Rosen (neuroimmunology), Irshad Ansari (membrane trafficking), and Brent Trauterman (lab operations). Alumni hold positions at universities and industry worldwide.